Quantification of mixed chimerism allows early therapeutic interventions

Quantification of mixed chimerism allows early therapeutic interventions

Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syndrome; however, it requires a long post-transplantation follow-up. A 53-year-old woman with a diagnosis of myelodysplastic syndrome underwent related donor allogeneic hematopoietic stem cell transplan...

Full description

Bibliographic Details
Main Authors:	Jóice Merzoni, Gisele Menezes Ewald, Alessandra Aparecida Paz, Liane Esteves Daudt, Luiz Fernando Job Jobim
Format:	Article
Language:	English
Published:	Elsevier 2014-10-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Chimerism Bone marrow transplantation Myelodysplastic myeloproliferative diseases Tandem repeat sequences
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000500369&lng=en&tlng=en

Similar Items

A prenatal case misunderstood as specimen confusion: 46,XY/46,XY chimerism
by: Lin Chen, et al.
Published: (2024-02-01)

Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation
by: Azulamara da Silva Ruiz, et al.

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01)

Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
by: Lucía Prieto-Torres, et al.
Published: (2023-12-01)

Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
by: Qian Wang, et al.
Published: (2020-01-01)

Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation
by: Heerah Lee, et al.
Published: (2024-02-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Leucemia mielomonocítica crónica
by: Yamilé Quintero-Sierra, et al.

Pancytopenia: Clinical and Haematological Profile from a Tertiary Care Centre in Central India
by: Shweta Jain, et al.
Published: (2022-04-01)

Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
by: Asude Kara Polat, et al.
Published: (2017-01-01)

Genetic mutations associated with blood count abnormalities in myeloid neoplasms
by: Chantana Polprasert, et al.
Published: (2022-12-01)

Comparison of single nucleotide polymorphisms and short tandem repeats as markers for differentiating between donors and recipients in solid organ transplantation
by: Hyun-Ji Lee, et al.
Published: (2021-03-01)

Chronic Myelomonocytic Leukemia Gold Jubilee
by: Eric Solary, et al.
Published: (2021-07-01)

Landscape of genetic alterations of myeloid neoplasms in 305 Chinese cases
by: GOU Yang, et al.
Published: (2019-11-01)

Acute graft-versus-host disease after double lung transplant confirmed by short tandem repeat analysis to identify donor chimerism in the skin
by: Jesus Valencia, BS, et al.
Published: (2023-06-01)

Bone marrow cell migration to the heart in a chimeric mouse model of acute chagasic disease
by: Camila Iansen Irion, et al.

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Quantitative analysis of chimerism after allogeneic hematopoietic stem cell transplantation with molecular genetic methods
by: V. A. Lavrinenko, et al.
Published: (2014-09-01)

Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
by: Philipp Ernst, et al.
Published: (2021-02-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

The association of bladder myeloid sarcoma and unclassified myelodysplastic/myeloproliferative disease
by: Mehmet Sönmez, et al.
Published: (2009-06-01)

Treatment of refractory anemia with ring sideroblasts associated with marked thrombocytosis with lenalidomide in a patient testing negative for 5q deletion and JAK2 V617F and MPL W515K/L mutations
by: Ryan Keen, et al.
Published: (2016-11-01)

Acute myeloid leukaemia with myelodysplasia-related change in a child living with human immunodeficiency virus infection, a transformation from underlying juvenile myelomonocytic leukaemia
by: Vongai Mashoko, et al.
Published: (2020-12-01)

Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study
by: Cristina Bucelli, et al.
Published: (2021-10-01)

Reduced toxicity conditioning and a high CD34+ cell dose can achieve full donor chimerism in DOCK8 deficiency
by: Ambreen Pandrowala, MBBS, DNB (Paediatrics), et al.
Published: (2023-08-01)

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
by: Jennifer Marvin-Peek, et al.
Published: (2022-01-01)

DeepRepeat: direct quantification of short tandem repeats on signal data from nanopore sequencing
by: Li Fang, et al.
Published: (2022-04-01)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021-11-01)

Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR
by: Felicitas Schulz, et al.
Published: (2023-10-01)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
by: Mohamed A. Yassin, et al.
Published: (2023-01-01)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
by: Marion Delplanque, et al.
Published: (2022-04-01)

Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question
by: Wilma Barcellini, et al.
Published: (2021-09-01)

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
by: Carlo Pescia, et al.
Published: (2021-10-01)

Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective
by: Clare Zimmerman, et al.
Published: (2020-08-01)

Determination of the donor : host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphisms
by: N Malik, et al.
Published: (2002-06-01)

Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis
by: Michele Dello Spedale Venti, et al.
Published: (2022-06-01)

Study of bone marrow microvessel density is one of the diagnostic approaches in patients with Ph-negative chronic myeloproliferative diseases
by: Manana Aleksandrovna Sokolova, et al.
Published: (2010-12-01)

Focus on Osteosclerotic Progression in Primary Myelofibrosis
by: Mariarita Spampinato, et al.
Published: (2021-01-01)

A model for the functional assessment of elderly with myeloid neoplasms
by: Ana Lúcia Ippolito Carbonell, et al.
Published: (2015-04-01)

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Michelle Maccarini Barcelos, et al.
Published: (2011-01-01)